Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: trachealbronchialmalcia s/p stent evaluation major surgical or invasive procedure: flexible bronchoscopy rigid and flexible bronchoscopy, stent removal triple lumen central line placement rigid bronchoscopy with remainder stent removal right upper extremity ultrasound bilateral lower extremity ultrasound mammogram and bilateral breast ultrasound history of present illness: mrs. is a 51 year-old female with trachaelbronchialmalacis & tracheal stenosis s/p stent placement 6 years ago now with dislodged/fractured stents she has been referred from for flexible bronchoscopy to further evaluate and management of stents and airway. past medical history: tracheal stenosis s/p stent removal trachealbronchialmalacia asthma hypertension diabetes mellitus cva right axillar and right internal jugular thrombus mastitis, bilateral social history: she lives with her family in and has five children. no ethanol, no tobacco, no recreational drugs. family history: non-contributory physical exam: general: 51 year-old spanishing speaking female in no apparent distress heent: normocephalic, mucus membranes moist neck: thick, no lymphadenopathy card: regular, rate & rhythm, normal s1,s2, no murmur/gallop or rub resp: decreased gi: obese, bowel sounds positive, abdomen soft non-tender/non-distended extr: warm, right upper extremity with 2+ edema, left non, lower extremity no edema pulses: (b) brachial, radial 2+ breast: bilateral erythema, warm & tender neuro: non-focal pertinent results: wbc-16.4*# rbc-3.75* hgb-9.1* hct-30.0 plt ct-228 wbc-7.7 rbc-3.17* hgb-7.4* hct-25.7 plt ct-340 pt-14.5* ptt-40.3* inr(pt)-1.3* glucose-278* urean-13 creat-0.8 na-147* k-3.9 cl-108 hco3-22 glucose-79 urean-6 creat-0.7 na-138 k-3.4 cl-102 hco3-27 cultures: 8:16 am swab source: rectal swab. r/o vancomycin resistant enterococcus (final ): no vre isolated. 8:16 am mrsa screen source: rectal swab. mrsa screen (final ): no mrsa isolated. 1:46 am sputum source: endotracheal. gram stain (final ): >25 pmns and <10 epithelial cells/100x field. 2+ (1-5 per 1000x field): gram positive cocci. in pairs, chains, and clusters. 2+ (1-5 per 1000x field): gram positive rod(s). 2+ (1-5 per 1000x field): gram negative rod(s). respiratory culture (final ): sparse growth oropharyngeal flora. gram negative rod(s). sparse growth. 12:10 pm tissue site: breast left breast abscess drainage. gram stain (pending): tissue culture-tissue (pending): anaerobic culture (pending): ct trachea w/o c w/3d rend secretions are demonstrated within the trachea. the diameter of the trachea is difficult to assess in the presence of the stent, although at least the diameter of the new stent which is about 13 mm. the right main bronchus, bronchus intermedius and right lower lobe bronchus are patent during the inspiration. narrowing of the orifice of the right middle lobe bronchus is demonstrated, although it is patent during inspiration. the left upper and left lower lobe bronchi are patent during inspiration. the dynamic expiration series demonstrate significant decrease of the diameter of the right main bronchus, from 7.7 to less than 3 mm with right middle lobe and right lower lobe origins almost collapsed on end-inspiration as a collapsed segmental bronchi in both lower lobes and right middle lobe with subsequent significant widespread areas of air trapping, most likely attributed to this dynamic airway collapse. the evaluation of the lung parenchima demonstrate multiple rounded opacities, in the right apex, 7:25, in right upper lobe, 7:33, 7:36, extensive areas of centrilobular ground-glass opacities and more rounded consolidations in right middle lobe and right lower lobe as well as in the left lung to a lesser extent, findings which are consistent with widespread infection/aspiration. there is no pleural or pericardial effusion. several mediastinal lymph nodes do not meet the size criteria for lymphadenopathy ranging up to 8 mm in right lower paratracheal, 10 mm in subcarinal and 5 mm in the aortopulmonic window. the heart size is mildly enlarged, stable compared to the previous studies. impression: 1. severe bronchomalacia as described, bilateral. the presence of the endotracheal stent prevents the evaluation of malacia. the newest internal stent is most likely broken. narrow lumen left in left main bronchus. 2. extensive areas of rounded consolidations, ground-glass opacities and centrilobular nodules are consistent with widespread infection/aspiration. differential diagnosis might include parenchymal hemorrhage in the appropriate clinical setup. chest (portable ap) 1:23 pm findings: compared to the film from earlier the same day there continues to be bilateral lower lobe volume loss with question infiltrate in the right and left lower lobes. the tracheal and left mainstem stents are unchanged. the left subclavian line is unchanged. unilat up ext veins us right 12:37 am right upper extremity venous ultrasound: grayscale and doppler son of the right internal jugular, subclavian, axillary veins were performed. the basilic and cephalic veins were not visualized. there is partially occlusive thrombus within a cm segment of the right internal jugular vein. there is an additional larger partially occlusive thrombus within a 2-3 cm segment of the right axillary vein. impression: partially occlusive thrombi within the right internal jugular and right axillary vein. bilat lower ext veins 8:49 am impression: no evidence of dvt. brief hospital course: mrs. underwent flexible bronchoscopy to evaluate stent placement and airway. on hd#2 she was taken to the operating room and underwent flexible and rigid bronchoscopy, foreign body (stent) removal and bronchoalveolar lavage. she was transferred to the intensive care unit intubated for airway management. she was started on intravenous antibiotics for her aspiration pneumonia. on pod #1 a central line was placed for access and intravenous antibiotics. she remained stable and on pod#3 was taken for a flexible bronchoscopy to further evaluate her airway. she was taken back to the surgical intensive care unit and was unable to extubate secondary to agitation. on she was taken back to the operating room for flexible and rigid bronchoscopy with silicone stent placement. she tolerated the procedure well and was extubated on without difficulty. she transferred to the floor in stable condition. she was restarted on her home medications. a clear liquid diet was started and advanced as tolerated. on she found to have right upper arm edema and a right upper extremity ultrasound was positive for a partially occlusive thrombi within the right internal jugular and right axillary vein. she was started on lovenox and coumadin. on she complained of bilateral breast tenderness and warmth. she was placed on keflex for possible mastitis. given her history of past dvts a lower extremity ultrasound was negative for dvt. on bilateral breast ultrasound revealed a small left-sided fluid collection which was drained for 1.5 cc of serous fluid. cultures were sent and results are pending. medications on admission: prednisone 30 mg once daily procardia 60 once daily lasix 40 once daily percs prn & morphine 100 mg tid albuterol, atrovent; xanax 0.5 tid zocor 20 qd ambien 10 qhs asa 325 mg once daily nitro prn insulin 70/30- 25am/15pm discharge medications: 1. clonidine 0.2 mg tablet sig: one (1) tablet po tid (3 times a day). 2. furosemide 40 mg tablet sig: one (1) tablet po daily (daily). 3. aspirin 81 mg tablet sig: one (1) tablet po once a day. 4. simvastatin 20 mg tablet sig: one (1) tablet po once a day. 5. insulin nph & regular human 100 unit/ml (70-30) cartridge sig: twenty five (25) units subcutaneous once a day. 6. guaifenesin 600 mg tablet sustained release sig: two (2) tablet sustained release po every twelve (12) hours: indefinitely for tracheal stents. disp:*60 tablet sustained release(s)* refills:*2* 7. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. 8. albuterol sulfate 2.5 mg/3 ml solution for nebulization sig: one (1) inhalation q6h (every 6 hours) as needed. 9. ipratropium bromide 0.02 % solution sig: one (1) inhalation q6h (every 6 hours). 10. alprazolam 1 mg tablet sig: one (1) tablet po tid (3 times a day) as needed. 11. ibuprofen 400 mg tablet sig: one (1) tablet po q8h (every 8 hours) as needed: take with food and water. 12. colace 100 mg capsule sig: one (1) capsule po twice a day. 13. enoxaparin 80 mg/0.8 ml syringe sig: one (1) subcutaneous q12h (every 12 hours): until inr > 2.0. 14. cephalexin 500 mg capsule sig: one (1) capsule po q6h (every 6 hours) for 14 days. 15. potassium chloride 20 meq tab sust.rel. particle/crystal sig: one (1) tab sust.rel. particle/crystal po daily (daily). 16. coumadin 1 mg tablet sig: take as directed to maintain inr 2.0-3.0 tablets po once a day. 17. regular insulin per sliding scale finger stick discharge disposition: extended care facility: discharge diagnosis: tracheal stenosis s/p stent removal trachealbronchialmalacia asthma hypertension diabetes mellitus cva right axillar and right internal jugular thrombus mastitis, bilateral discharge condition: stable discharge instructions: call interventional pulmonology as needed complete keflex course for mastitis lovenox 80 mg q12h for right axillar and right internal jugular thrombus coumadin inr goal 2.0-3.0: monitor inr and dose coumadin appropiately monitor fingerstick blood surgars before meals and bedtime cover with sliding scale continue albuteral and atrovent nebulizers mucinex 1200mg twice daily indefinitely monitor cbc, lytes, bun & cre follow-up on left breast fluid collection cultures. monitor left breast drain site for signs or symptoms of infection followup instructions: follow-up with your pcp in : for further coumadin management follow-up with interventional pulmonology as needed md procedure: venous catheterization, not elsewhere classified continuous invasive mechanical ventilation for 96 consecutive hours or more enteral infusion of concentrated nutritional substances other bronchoscopy other bronchoscopy other bronchoscopy arterial catheterization arterial catheterization other intubation of respiratory tract closed [endoscopic] biopsy of bronchus removal of intraluminal foreign body from trachea and bronchus without incision aspiration of breast diagnoses: unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled asthma, unspecified type, unspecified old myocardial infarction mechanical complication due to other implant and internal device, not elsewhere classified personal history of venous thrombosis and embolism other postprocedural status surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation inflammatory disease of breast other diseases of trachea and bronchus other late effects of cerebrovascular disease, facial weakness 

Answer: The patient is high likely exposed to